Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

Long term benefits following short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens, typified by psilocybin and ketamine respectively, support their potential as treatments for psychiatric conditions such as major depressive disorder. The high psychedelic...

Descripción completa

Detalles Bibliográficos
Autores principales: Higgins, Guy A., Carroll, Nicole K., Brown, Matt, MacMillan, Cam, Silenieks, Leo B., Thevarkunnel, Sandy, Izhakova, Julia, Magomedova, Lilia, DeLannoy, Ines, Sellers, Edward M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952974/
https://www.ncbi.nlm.nih.gov/pubmed/33716753
http://dx.doi.org/10.3389/fphar.2021.640241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952974/
https://www.ncbi.nlm.nih.gov/pubmed/33716753
http://dx.doi.org/10.3389/fphar.2021.640241

Ejemplares similares